CFTR and cystic fibrosis: Programs with the goal of increasing the specificity and positive predictive value of CF NBS, thereby reducing the number of sweat tests performed on infants who are likely CF carriers or who have CRMS/CFSPID, should identify infants as having a positive CF NBS only when two CF-causing, pathogenic, or likely pathogenic CFTR variants are detected by third-tier sequencing.